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Background and purpose — It has been suggested that the risk of 
prosthetic joint infection (PJI) in patients with total hip arthro-
plasty (THA) may be underestimated if based only on arthro-
plasty registry data. We therefore wanted to estimate the “true” 
incidence of PJI in THA using several data sources.
Patients and methods — We searched the Danish Hip Arthro-
plasty Register (DHR) for primary THAs performed between 
2005 and 2011. Using the DHR and the Danish National Regis-
ter of Patients (NRP), we identified first revisions for any reason 
and those that were due to PJI. PJIs were also identified using an 
algorithm incorporating data from microbiological, prescription, 
and clinical biochemistry databases and clinical findings from the 
medical records. We calculated cumulative incidence with 95% 
confidence interval.
Results — 32,896 primary THAs were identified. Of these, 
1,546 had first-time revisions reported to the DHR and/or the 
NRP.  For the DHR only, the 1- and 5-year cumulative incidences 
of PJI were 0.51% (0.44–0.59) and 0.64% (0.51–0.79). For the 
NRP only, the 1- and 5-year cumulative incidences of PJI were 
0.48% (0.41–0.56) and 0.57% (0.45–0.71). The corresponding 1- 
and 5-year cumulative incidences estimated with the algorithm 
were 0.86% (0.77–0.97) and 1.03% (0.87–1.22). The incidences of 
PJI based on the DHR and the NRP were consistently 40% lower 
than those estimated using the algorithm covering several data 
sources. 
Interpretation — Using several available data sources, the 
“true” incidence of PJI following primary THA was estimated 
to be approximately 40% higher than previously reported by 
national registries alone.

PJI is the third most common indication for revision of total 
hip arthroplasty (THA), accounting for approximately 15% of 
all revisions (Bozic and Ries 2005, Dale et al. 2012). Studies 
have shown that the incidence of PJI is currently on the rise 
(Kurtz et al. 2008, Dale et al. 2012). Despite this increase, the 
reported 5-year cumulative incidence of infection following 
primary THA in the Scandinavian countries—based on the 
validated arthroplasty registries alone (Soderman et al. 2000, 
Pedersen et al. 2004, Arthursson et al. 2005)—is less than 1%. 
However, reliance on a single arthroplasty registry for iden-
tification of revision due to infection may lead to an under-
estimation of the true incidence (Swedish Hip Arthroplasty 
Register, Arthursson et al. 2005, Espehaug et al. 2006, Jamsen 
et al. 2009, Dale et al. 2011). The definitive diagnosis of revi-
sion due to joint infection is based on intraoperative cultures, 
the results of which are often unknown at the time of registra-
tion, introducing the problem of misclassification of diagnosis 
when the indication is based entirely on the judgment of the 
surgeon. In addition, lower registration of revisions than of 
primary procedures is a general problem in arthroplasty reg-
istries. A more realistic estimate of the incidence of PJI may 
be found by combining different data sources (Huotari et al. 
2010).
The aim of this study was to determine the “true” incidence 
of first-time revision due to PJI following primary THA using 
several data sources, and to compare it with that derived from 
single registries.
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Material and methods
Setting
We conducted this population-based cohort study using pro-
spectively collected data available from nationwide medical 
registries in Denmark, a country with 5.6 million inhabitants. 
The Danish National Health Service provides tax-supported 
healthcare for all Danish citizens. Free medical care is guar-
anteed for emergency and general hospital admissions, and 
for outpatient clinic visits. All Danish citizens are assigned a 
unique civil registration number, either at birth or upon immi-
gration; this encodes date of birth and sex. The number is 
recorded for all healthcare contacts, and this allows unambig-
uous linkage between all the Danish population-based admin-
istrative and health registers (Pedersen 2011).
The Danish Arthroplasty Register (DHR) was used to 
identify a cohort of patients undergoing primary THA. The 
patients in this cohort were then followed until death, emigra-
tion, or first-time revision. First-time revisions were identified 
using the DHR or the National Register of Patients (NRP). In 
addition, the DHR, the NRP, and additional information from 
databases on microbiology, prescriptions, and clinical bio-
chemistry together with medical records were used to classify 
the revisions as being due to PJI or to other causes.
The primary THA study population
The Danish Hip Arthroplasty Register (DHR) was used to iden-
tify a cohort of primary THA patients, from here on referred 
to as the study population. The DHR is a nationwide database 
covering primary THAs, revisions, and postoperative complica-
tions. Registration of primary THAs and revisions is compul-
sory for orthopedic departments in public hospitals and private 
clinics in Denmark. The data are filled out by the operating sur-
geon on a standard form immediately after surgery. A detailed 
description of the DHR is available elsewhere (www.dhr.dk). 
The DHR was validated in 2004 (Pedersen et al. 2004) and this 
is an ongoing activity as part of annual reports. The registry has 
information on the date of surgery and the operative side.
The study population included all the patients who were reg-
istered in the DHR as having had a primary THA operation 
performed between January 1, 2005 and December 31, 2011 
in a hospital or clinic in the Jutland or Funen province. The 
2 provinces have a total population of 3 million, representing 
54% of the entire Danish population, and the age and sex distri-
bution is the same as in the rest of the Danish population (Statis-
tics Denmark); the completeness of registration is also similar. 
The patients were checked for missing or incorrect informa-
tion regarding civil registration number, operative side, date of 
operation, and indication (Figure 1). All revised patients from 
the study population were linked to their subsequent revision.
Identification of first-time revision for any reason
The following sources of data were used for identification of 
first-time revision for any reason.
The Danish Hip Arthroplasty Register (DHR): In the DHR, 
the indication for revision THA is recorded as aseptic loosen-
ing, wear of polyethylene without loosening, deep infection, 
fracture of the femur, dislocation of the hip, pain, osteoly-
sis, and other less frequent causes. Procedures that involved 
exchange of only part of the prosthesis (e.g. exchange of cup 
or liner alone) and debridement without exchange or removal 
of any part of the prosthesis were also included in the study 
and defined as revision.
The Danish National Register of Patients (NRP): The NRP 
was also used for identification of any revision. The NRP has 
been a national administrative health registry for all admis-
sions and discharges from somatic public hospitals since 
1977, and for all hospital outpatient and emergency visits 
since 1995. Since 1995, compulsory reporting to the NRP has 
included the civil registration number, date of admission, and 
physician-derived discharge diagnoses according to the Danish 
version of the International Classification of Diseases Tenth 
Edition (ICD-10), and surgical procedure codes according to 
the Nordic Medico-Statistical Committee (Nordic Centre for 
Classifications in Health Care 2008). The following surgical 
procedure codes are defined as revision surgery in the NRP: 
KNFC20-99, “revision with secondary insertion of hip pros-
thesis”; KNFU1, “removal of hip prosthesis”; KNFG09-29, 
“other kind of hip arthroplasty”; KNFW69, “revision because 
of deep infection”; and KNFS19 or KNFS49, “incision and 
revision because of prosthetic infection”.
Using the unique civil registration number, operative side, 
and date of primary THA operation for patients in the study 
population, we searched the DHR and the NRP for any subse-
quent revisions performed in Denmark from January 1, 2005 
to December 31, 2012, which allowed a follow-up period of 
at least 1 year (Figure 1). First-time revisions were defined 
as the earliest registered revision after  primary THA. If the 
date of operation reported to the DHR was different from that 
reported to the NRP, the earlier of the 2 was included and the 
second one was considered a second revision (and was there-
fore excluded) (Figure 1).
Identification of first-time revision due to prosthetic 
joint infection
Information on revision due to PJI was collected from the 
DHR (using deep infection as indication for revision) and the 
NRP (using the diagnosis DT845*, “infection or inflammation 
in the area of a prosthesis” in combination with one of the sur-
gical procedure codes for revision described above). 
In addition, the following data sources were used:
The microbiological laboratory information system (LIS): 
Each Department of Clinical Microbiology (DCM) serving 
Danish hospitals maintains an electronic LIS. All the DCMs 
that served a hospital in which a revision was performed pro-
vided culture reports for this study, i.e. the DCM at Aalborg 
University Hospital, Aarhus University Hospital, West and 
Central Jutland Regional Hospital, Vejle Hospital, South-
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ern Jutland Hospital, Southwest Jutland Regional Hospital, 
Odense University Hospital, Slagelse Hospital, Rigshospi-
talet, and Naestved Hospital. Information was collected on 
cultures taken intraoperatively by tissue biopsy. As a rule, a 
number of samples (preferably 5) were obtained in the vicin-
ity of the prosthesis and handled separately in the laboratory 
according to the principles of Kamme and Lindberg (Kamme 
and Lindberg 1981, Lorentzen and Sørensen 1986). All intra-
operative samples were in culture for at least 4 days.
Prescription databases: The Universities of Aarhus and 
Southern Denmark maintain prescription databases, with 
data submitted by community pharmacies on all reimburs-
able prescription drugs for outpatient use (Johannesdottir et 
al. 2012). Patients were regarded as having received antibi-
otic treatment before revision if a prescription for an antibiotic 
had been redeemed and the treatment had lasted to within 2 
weeks before the revision, which was determined by the dis-
pensing date, defined daily dose (DDD), pack size, strength, 
and the number of packets or units and the information could 
be corroborated by review of the medical records. Lists of the 
ATC (Anatomic Therapeutic Chemical Classification System) 
codes used to identify antibiotics and the antibiotic prescrip-
tions redeemed by patients in the study population are given in 
Appendix A (see Supplementary data).
Clinical biochemistry databases: The databases are main-
tained by the departments of clinical biochemistry at the 
hospitals undertaking the THA revisions (Grann et al. 2011). 
Information was retrieved for plasma C-reactive protein 
(CRP). If the database reported the CRP in nmol/L, a conver-
sion factor of 9.524 mg/nmol was used. The normal range was 
set at < 10 mg/L.
Medical records: The medical records were either accessed 
at the hospital that performed the revision surgery or through 
the e-journal database maintained by the Ministry of Public 
Health, jointly with the Danish Regions. We extracted infor-
mation about previous use of antibiotics, presence of a sinus 
tract, date of operation, operative side, and description of 
purulence in the operation notes.
Algorithm
To identify a PJI, we developed an algorithm based on 
multiple data sources from microbiology, clinical findings 
described in the medical record, antibiotic treatment prior to 
the revision, and preoperative CRP levels < 10 mg/L (Fig-
ures 2 and 3). A more detailed explanation of the algorithm 
is presented in Appendix B (see Supplementary data).  We 
defined a PJI following a primary THA as a first-time revi-
sion reported to the DHR and/or the NRP that could be clas-
Figure 1. Revisions identified in either the DHR or the NRP.
a Missing or incorrect information regarding the civil registration number, operative side, date of operation, or indication.
b Excluded, as a previous revision was reported to the other registry.
THA reported to FHR
January 1, 2005 to December 31, 2011
in Jutland and Funen
n = 33,353
Excluded due to 
error in registration a
n = 457
Excluded due to 
error in operation side
n = 25
Eligible primary THA
n = 32,896
Registered in NRP
with a revision
n = 1,392
Revisions found
only in NPR
n = 280
Revisions found
only in DHR
n = 172
Emigrated
n = 172
Dead
n = 3,751
Followed until
December 31, 2012
without any revision
n = 27,559
Revisions found
in both NPR and DHR
n = 1,095
First-time revisions due to any cause performed
January 1, 2005 to December 31, 2012 
n = 1,522
Registered in DHR
with a revision
n = 1,392
Not first time
revision b
n = 65
Not first time
revision b
n = 17
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sified as having been performed due to deep infection, based 
on our algorithm:
A: A PJI was defined by microbiology if the same microor-
ganism was isolated from 3 or more biopsies taken during 
surgery (Kamme and Lindberg 1981, Atkins et al. 1998, 
Mikkelsen et al. 2006) and the microorganism isolated 
was not a spore-forming bacterium of questionable signifi-
cance.
Figure 2. Algorithm for classification of the1,522 first-time revisions performed because of deep infection or other causes.
Yes
n = 2
No
n = 15
No
n = 1,233
From Figure 1
n = 1,522
Prosthetic joint
infection
No
infection
No
n = 477
No
n = 460
Yes
n = 5
Yes
n = 17
No
n = 234No
n = 751
No
n = 87
Yes
n = 289
Yes
n = 68
Yes
n = 819
≥ 5
n = 906
< 5
n = 327
≥ 3 positive periprosthetic (A) 
cultures with phenotypically 
identical organisms
Is there a sinus tract  (C)
from skin to prosthesis?
Total number of  (D)
cultures > 5?
Is CRP above   (E)
10 mg/L?
Algorithm 
continues
on Figure 3
Reported as infected in DHR/NRP
or
receiving antibiotics within
14 days prior to revision
or
positive aspiration (synovial fluid)
Total number of cultures (B)
All cultures are negative (B)
Audit
Yes
n = 226
  (B)
Figure 3. Algorithm (continued) for classification of the revisions performed due to periprosthetic joint infection or other causes.
Intra-articular purulence (F) 
From Figure 2
n = 226
≥ 1
n = 23
Yes
n = 21
Total no.
n = 170
No
n = 22
Yes
n = 13
No
n = 157
0
n = 48
not
cultured
n = 130
positive
n = 1
negative/
not cultured
n = 22
2 of the
same 
species
n = 25
Number of   (F)
positive cultures 
Result of  (F)
aspiration 
positive
n = 5
negative/
not cultured
n = 43
positive
n = 8
not cultured
n = 122
Receiving antibiotics
within 14 days
prior to revision
(F)
Prosthetic joint
infection
No
infection
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B: Revision THA was classified as being due to causes other 
than infection if: ≥ 5 intraoperative cultures were taken and 
all of them were negative (Atkins et al. 1998, Trampuz et 
al. 2007), the indication for revision in either the DHR or 
the NRP was reported as a cause other than infection, the 
patient was not treated with antibiotics prior to revision 
(Trampuz et al. 2007, Malekzadeh et al. 2010), and there 
was no positive culture from the aspiration of joint fluid 
(Lachiewicz et al. 1996, Malhotra and Morgan 2004, Wil-
liams et al. 2004).
C: If any of the statements in B were positive, the medical 
record was reviewed to identify whether a sinus tract com-
municating with the prosthesis had been observed (Zim-
merli et al. 2004, Parvizi and Gehrke 2013).
D: If more than 5 intraoperative cultures had been taken, an 
audit was performed by the authors in order to classify the 
revision as having been performed due to PJI or no infec-
tion. The audit was done to ensure that 2 or more posi-
tive cultures did not automatically lead to a revision being 
classified as deep infection if the 2 positive cultures were 
the result of a large number of intraoperative cultures (e.g. 
10–15). 
E: If the CRP was >10 mg/L and had been measured within 
30 days before the date of revision, the indication for per-
forming the revision was classified according to the algo-
rithm (continued in Figure 3) using the result of aspiration, 
intraoperative cultures (with prior use of antibiotics taken 
into account), and the presence of purulence. If CRP was 
not measured or it was <10 mg/L, the revision was clas-
sified as being due to other causes (Bernard et al. 2004, 
Savarino et al. 2004, Schinsky et al. 2008).
Note: For all stages in Figure 3, it is an underlying premise 
that the CRP was measured and found to be >10 mg/L.
F:  2 positive intraoperative cultures with growth of the same 
microorganism, as judged by phenotypic characters, were 
diagnostic for a PJI (Atkins et al. 1998, Mikkelsen et al. 
2006, Trampuz et al. 2007, Schafer et al. 2008). A single 
positive culture or 2 positive cultures revealing different 
microorganisms (or different phenotypes) with the pres-
ence of purulence or a positive culture from joint fluid 
aspiration were diagnostic for a PJI (Atkins et al. 1998, 
Zimmerli et al. 2004, Trampuz et al. 2007, Schafer et al. 
2008). If none of the cultures were positive, the likeli-
hood of infection was considered to be low (Kamme and 
Lindberg 1981, Atkins et al. 1998, Mikkelsen et al. 2006, 
Trampuz et al. 2007, Schafer et al. 2008) unless the patient 
had been given antimicrobial therapy prior to the revision 
(Trampuz et al. 2007, Malekzadeh et al. 2010). Thus, if all 
intraoperative cultures were negative, the revisions were 
defined as having been done for causes other than infec-
tion, unless the patient had received antibiotics prior to the 
revision. Aspirations of joint fluid are considered to have 
low to moderate sensitivity and high specificity (Lachie-
wicz et al. 1996, Malhotra and Morgan 2004, Williams et 
al. 2004). Thus, a positive aspiration was given consider-
able weight in determining that a revision had been per-
formed due to infection, whereas a negative aspiration had 
less of an influence in ruling out infection.
G: The presence of purulence has been regarded as a definite 
sign of infection (Zimmerli et al. 2004, Parvizi et al. 2011b) 
but it remains a subjective measurement (Biant et al. 2010, 
Blumenfeld et al. 2010, Molvik et al. 2010). The presence 
of purulence was therefore only regarded as a definite sign 
of infection if supported by other observations (e.g. ele-
vated CRP or positive intraoperative cultures) or if nega-
tive intraoperative cultures could be explained by previous 
use of antibiotics.
Statistics
The cumulative incidence with 95% confidence interval (CI) 
was calculated as the proportion of the cohort in which a revi-
sion was performed. In accordance with the guidelines for sta-
tistical analysis of arthroplasty data, the cumulative incidence 
function was used to adjust for competing risks (death, emi-
gration, and— in the estimation of PJI—revision due to causes 
other than infection) (Ranstam et al. 2011). The cumulative 
incidence of revisions for any reason was estimated for the 
DHR and NRP, separately and in combination. The cumula-
tive incidence of PJI was calculated for the DHR, for the NRP, 
and according to our algorithm. For the 2- and 5-year cumula-
tive incidences (with 95% CI), only primary THAs that were 
operated on between January 1, 2005 and December 31, 2010, 
and between January 1, 2005 and December 31, 2007 were 
included. All cases were observed until the date of the first-
reported revision in the DHR and/or NRP, death, emigration, 
or 1, 2, or 5 years after the primary THA. Bilateral hip pros-
theses are not independent observations (Ranstam et al. 2011), 
but as none of the patients had a PJI in both hips, the effect of 
bilaterality was considered negligible. Data management and 
statistical analyses were performed with STATA12 software. 
Ethics
The study was approved by the National Board of Health 
(journal no. 3-3013-303/1/) and the Danish Data Protection 
Agency (journal no. 2008-58-0035).
results
We identified 32,896 primary THAs in 29,077 patients in our 
study population (Figure 1). The median age of patients with a 
primary THA was 69 (11–98) years. 55% of the patients were 
female.
First-time revisions for any reason
For the entire study period (January 1, 2005 through Decem-
ber 31, 2011), 1,332 and 1,392 first-time revisions were iden-
tified in the DHR and NRP, respectively. A combined total 
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of 1,546 first-time revisions were identified; of these, 1,095 
(71%) were found in both registries. The main reasons for lack 
of agreement between the DHR and the NRP were erroneous 
registration of the operative side and registration of a proce-
dure code in the NRP that we had not defined as a revision.
The cumulative incidence of first-time revisions for any 
reason in the first year of follow-up was 2.83 (2.65–3.01) when 
the combined registries were used. Separately, the incidence 
for any reason was 2.22 (2.06–2.38) in the DHR, and it was 
2.55 (2.39–2.73) in the NRP (Table 1). For all time periods (1, 
2, and 5 years), the NRP consistently underestimated the inci-
dence of first-time revisions by 10%, and the DHR by 20%, 
compared to the combined estimates using both the DHR and 
the NRP. There was a statistically significant increase in the 
cumulative incidence from 1 to 5 years of follow-up.
First-time revision due to prosthetic joint infection
Of all the 1,332 revisions identified in the DHR, 227 (17%) 
were reported to be due to infection. For the NRP, 207 out 
of 1,392 revisions (16%) were due to infection. The 1-year 
cumulative incidences of PJI were 0.51% (0.44–0.59) for the 
DHR and 0.48% (0.41–0.56) for the NRP (Table 2). There was 
no statistically significant difference in the cumulative inci-
dences of infection estimated from the DHR alone and from 
the NRP alone.
After review of the medical records for information on sinus 
tract, presence of purulence, and previous use of antibiotics, 3 
primary THAs and 25 first-time revisions were excluded from 
the study due to misclassification of operative side, procedure 
code, or date of operation. 1,522 first-time revisions remained, 
343 (23%) of which could be classified as PJI according to our 
algorithm (Figure 2). 
Intraoperative samples had been obtained for culture in 
1,210 revisions (80%). Most infections, 285 (83%) in the pres-
ent study, had occurred within the first year of the primary 
THA. The cumulative incidence of infection estimated by our 
algorithm was approximately 40% higher than reported by the 
DHR and NRP for the entire study period (Table 2 and Figure 
4).
discussion
To our knowledge, this is the first study to use several data 
sources, including microbiology, for estimation of the inci-
dence of surgically treated PJI in primary THA. We found 
that the “true” cumulative incidence using our algorithm was 
approximately 40% higher for the 1-, 2-, and 5-year follow-up 
periods than the incidences reported by the validated Danish 
registries (the DHR and the NRP).
Methodological considerations 
A key strength of this study was the number of data sources 
used for identification of prosthetic infections, combined 
Table 1. Cumulative incidence of revision for any reason following 
total hip arthroplasty (THA)
Register No. of No. of Cumulative incidence (%)
 primary THAs  revisions (95% CI)
1 year
 DHR 32,896 730 2.22 (2.06–2.38)
 NRP 32,896 839 2.55 (2.39–2.73)
 Combined 32,896 930 2.83 (2.65–3.01)
2 years
 DHR 27,906 802 2.87 (2.68–3.08)
 NRP 27,906 893 3.20 (3.00–3.41)
 Combined 27,906 990 3.55 (3.34–3.77)
5 years
 DHR 13,175 560 4.25 (3.92–4.60)
 NRP 13,175 589 4.54 (4.19–4.90)
 Combined 13,175 662 5.02 (4.66–5.41)
DHR: the Danish Hip Arthroplasty Register; 
NRP: the National Register of Patients.
Table 2. Cumulative incidence of prosthetic joint infection following 
primary total hip arthroplasty (THA)
Register No. of No. of Cumulative incidence (%)
 primary THAs  revisions (95% CI)
1 year
 DHR 32,896 167 0.51 (0.44–0.59)
 NRP 32,896 158 0.48 (0.41–0.56)
 Algorithm 32,893 285 0.86 (0.77–0.97)
2 years
 DHR 27,906 185 0.61 (0.52–0.70)
 NRP 27,906 150 0.54 (0.46–0.63)
 Algorithm 27,903 266 0.96 (0.85–1.08)
5 years
 DHR 13,175   84 0.64 (0.51–0.79)
 NRP 13,175   75 0.57 (0.45–0.71)
 Algorithm 13,172 136 1.03 (0.87–1.22)
DHR: the Danish Hip Arthroplasty Register; 
NRP: the National Register of Patients.
Figure 4. Prosthetic joint infections over 1 year, with 95% CI.
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with the ability to perform accurate linkage and follow-up by 
means of the unique civil registration number assigned to all 
residents of Denmark. Thus, only 40 patients (0.1%) were lost 
to follow-up, all of them due to emigration. The microbiology 
databases, which provided information on the intraoperative 
cultures of a minimum of 3 samples for 1,210 revisions (80%), 
contributed especially to the diagnosis of a large number of 
previously unidentified infections.
More than 90% of the intraoperative cultures included 5 
samples (4–6 samples in more than 95% of the sets). This 
appears to reflect the work of Kamme and Lindberg in 1981, 
and the efforts of the scientific societies in Denmark to pro-
mote a consensus on the diagnosis, treatment, and prevention 
of PJI (Lorentzen and Sørensen 1986). Thus, even though data 
were collected from 29 orthopedic departments and intraop-
erative cultures were examined in 9 different microbiology 
departments, there was great similarity in the way that cultures 
were obtained.
However, building of a study on several data sources is also 
a weakness. Most diagnoses in the DHR and NRP have been 
validated (Andersen et al. 1999, Pedersen et al. 2004), but 
some of the codes for revision procedures have not yet been 
validated. So erroneous misclassifications of revisions cannot 
be fully accounted for. Both the DHR and the NRP have pre-
viously been shown to have a high degree of completeness 
(Pedersen et al. 2004, Arthursson et al. 2005), but our results 
indicate that for our study population, the registries have a 
completeness of between 80–90%. There is therefore a risk 
that some revisions might have been missed by both registers, 
which may have affected our estimate of first-time revisions.
Estimation of the true incidence of PJI is problematic, due to 
the inherent difficulties in making an unquestionable diagno-
sis of a PJI due to the lack of a universally accepted definition, 
as described in several papers and reviews (Bauer et al. 2006, 
Della Valle et al. 2010, Parvizi et al. 2011a). The International 
Consensus Meeting on Periprosthetic Joint Infection (Parvizi 
and Gehrke 2013) formulated a definition that was accepted 
by 85% of the physicians present, but that definition requires 
analyses that are not in routine use in Denmark, such as eryth-
rocyte sedimentation rate, aspiration of joint fluid, white blood 
cell count in joint fluid, and histological examination of intra-
operative tissue biopsies. We have tried to cover this by basing 
the algorithm on the most widely accepted definitions of a PJI, 
bestowing great importance on intraoperative cultures (Zim-
merli et al. 2004, Parvizi and Gehrke 2013).
In our algorithm, a normal CRP (< 10 mg/L) or missing CRP 
value was used to determine whether a revision should be clas-
sified as being due to causes other than infection. A normal 
CRP has a high negative predictive value, but some cases of 
late low-grade infection may be classified as false negative—as 
the CRP is not always elevated in these kinds of infections. By 
not using the CRP in the algorithm, we might avoid classifica-
tion of these cases as false negatives, but this would undoubt-
edly lead to a larger percentage of false positives. 
For some of the patients, we were not able to identify a 
preoperative CRP. Naturally, it is not possible to estimate 
the negative predictive value of a missing CRP. However, as 
most Danish surgeons would request a CRP before revision 
if there was any doubt concerning aseptic loosening or infec-
tion, we believe that classification of revisions as not having 
been infected based on missing CRP values does not affect 
our results greatly; however, any effect would result in an even 
higher incidence. This was confirmed in the 146 revisions 
where CRP was not measured prior to the revision, as only 
15 cultures showed growth and only 3 of them had more than 
one positive culture. Purulence was not found in any of these 
revisions, and none of them were reported in the DHR or the 
NRP as being due to infection.
Purulence has previously been regarded as a definitive sign 
of infection (Zimmerli et al. 2004, Parvizi et al. 2011a), but in 
recent years it has been downgraded due to subjective assess-
ment. In a number of case reports, purulence was found during 
revision but infection remained unconfirmed (Biant et al. 2010, 
Blumenfeld et al. 2010, Molvik et al. 2010). In the present 
study, only 7 cases were diagnosed as infected based solely on 
elevated CRP and the presence of purulence. These patients 
had been treated with antibiotics before the revision, result-
ing in all intraoperative cultures being negative or cultures not 
being taken. This is a weakness, but it also reflects problems 
in the daily routine of revision surgery. In future studies, this 
conundrum may be solved by the use of molecular diagnostic 
methods without the limitations of culture techniques.
Comparisons with previous studies
The 5-year cumulative infection rates reported by the DHR 
(0.64%) and the NRP (0.57%) are similar to the 0.62% 
(0.60–0.65) reported by Dale et al. (2012) in a study based 
on the NARA register that included 2,778 revisions due to 
prosthetic infection from a total of 432,168 primary THAs. 
This indicates that our study population and the registration 
of infection represent the general population of primary THAs 
reported in Scandinavia. Ong et al. (2009) reported an inci-
dence of infection for elective THA in the United States Medi-
care population of 0.78 over 2 years. This is higher than the 
2-year incidence proportion reported by the DHR (0.61%) and 
the NRP (0.54%), but less than the 0.94% that we found using 
the algorithm. However, a comparison between the studies is 
difficult, as the Medicare population is older than 65 years of 
age and was different from our population regarding socioeco-
nomic structure.
The Swedish Hip Arthroplasty Register Annual Report of 
2011 described a study in which a linkage between the regis-
try and the Swedish prescription database was used to identify 
patients treated with at least 1 month of antibiotics within 2 
years after a primary THA. For each patient treated with anti-
biotics, both a questionnaire and a list of the antibiotics pre-
scribed for the patients were sent to the clinic that performed 
the primary THA, asking the clinic to extract data from medi-
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cal records on whether PJI was the cause of antibiotic treatment 
and whether the patient had been operated due to infection. The 
study showed that only 67% of the revisions due to infection 
were reported to the register. Of all the infections diagnosed, 
94% underwent revision to treat the infection (Swedish Hip 
Arthroplasty Register). This supports the findings of our study 
that PJI is underestimated by national registries, but it also 
indicates that we did not estimate the true incidence of infec-
tion—but rather estimated the true incidence of infection that 
necessitated revision surgery. We chose not to include patients 
treated only with antibiotics, as it was considered impossible 
to differentiate wound drainage and a superficial surgical site 
infection from a true PJI when a revision was not performed.
2 or more prosthetic cultures with phenotypically identical 
organisms or a sinus tract communicating with the joint are 
generally used to diagnose infection (Zimmerli et al. 2004, 
Parvizi and Gehrke 2013). We chose not to use this definition, 
as we did not find enough studies that could validate a limit 
of 2 or more positive intraoperative cultures. If, however, we 
applied this definition (of 2 or more prosthetic cultures with 
phenotypically identical organisms or a sinus tract) to our 
data, 325 revisions could be classified as being due to PJI; 
of these, 9 were not classified as infected according to our 
algorithm. The estimated cumulative incidence based on this 
generally accepted definition was lower, but it was not statisti-
cally significantly different from our estimate.
The major reason for underestimating prosthetic infection 
in the DHR and the NRP may be that reporting to the regis-
tries is often based on subjective assessments of purulence or 
tissue inflammation, while other information such as defini-
tive culture reports may not always be available at the time 
of reporting. In addition, surgeons most likely do not change 
their reporting to the registry if later culture reports show that 
a presumed aseptic loosening has in fact been a deep infection.
The national registries in Scandinavia have proven to be a 
useful tool in research, monitoring improvements in THA sur-
gery. How the underestimation of PJI will affect the results 
of previous and future studies from the registries will depend 
entirely on the research question raised in individual studies. 
While absolute estimates of the incidence of PJI reported so 
far in studies from national hip registries is lower and only a 
conservative estimate of the true incidence, the relative risk 
estimates reported in numerous studies may not have been 
affected.
Conclusion
 In the Danish national registries, the 1- and 5-year cumulative 
incidences of surgically treated prosthetic joint infection were 
approximately 0.50% and 0.60%. The corresponding 1- and 
5-year cumulative incidences estimated by the algorithm were 
0.86% (0.77–0.97) and 1.03% (0.87–1.22). Thus, the use of 
multiple data sources for estimation of the “true” incidence 
of surgically treated PJIs led to a 40% higher estimate than 
reported by national arthroplasty and patient registries alone.
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